Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barry H Greenberg

Showing results (31-40 of 142) with videos related to

Pageof 15
Sort By:
The American Journal of Cardiology|October 7, 2006
Pharmacokinetic profile of controlled-release carvedilol in patients with left ventricular dysfunction associated with chronic heart failure or after myocardial infarctionMilton Packer, Mary Ann Lukas, David M Tenero, et al.
Journal of the American College of Cardiology|October 19, 2006
Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomesThomas Rutledge, Veronica A Reis, Sarah E Linke, et al.
The American Journal of Cardiology|October 7, 2006
COMPARE: comparison of the effects of carvedilol CR and carvedilol IR on left ventricular ejection fraction in patients with heart failureBarry H Greenberg, Mandeep Mehra, John R Teerlink, et al.
Journal of Molecular and Cellular Cardiology|March 1, 2005
IL-1beta and TNF-alpha upregulate angiotensin II type 1 (AT1) receptors on cardiac fibroblasts and are associated with increased AT1 density in the post-MI heartDevorah Gurantz, Randy T Cowling, Nissi Varki, et al.
Congestive Heart Failure (Greenwich, Conn.)|September 16, 2009
Sleep and health-related quality of life in heart failurePaul J Mills, Joel E Dimsdale, Loki Natarajan, et al.
JACC. Heart Failure|March 14, 2021
Thromboembolism in Heart Failure Patients in Sinus Rhythm: Epidemiology, Pathophysiology, Clinical Trials, and Future DirectionAndrew Y Lin, Elisabetta Dinatolo, Marco Metra, et al.
Journal of Cardiac Failure|April 3, 2012
Design and performance of a multisensor heart failure monitoring algorithm: results from the multisensor monitoring in congestive heart failure (MUSIC) studyInder S Anand, W H Wilson Tang, Barry H Greenberg, et al.
Brain, Behavior, and Immunity|February 17, 2009
Circulating levels of soluble intercellular adhesion molecule-1 (sICAM-1) independently predict depressive symptom severity after 12 months in heart failure patientsPetra H Wirtz, Laura S Redwine, Sarah Linke, et al.
American Journal of Physiology. Heart and Circulatory Physiology|May 10, 2005
Effects of cytokine treatment on angiotensin II type 1A receptor transcription and splicing in rat cardiac fibroblastsRandy T Cowling, Xiaowei Zhang, Vanessa C Reese, et al.
American Journal of Physiology. Heart and Circulatory Physiology|July 19, 2005
Angiotensin-(1-7) binds to specific receptors on cardiac fibroblasts to initiate antifibrotic and antitrophic effectsMichikado Iwata, Randy T Cowling, Devorah Gurantz, et al.
Pageof 15

Showing results (31-40 of 142) with videos related to

Sort By:
Pageof 15
The American Journal of Cardiology|October 7, 2006
Pharmacokinetic profile of controlled-release carvedilol in patients with left ventricular dysfunction associated with chronic heart failure or after myocardial infarctionMilton Packer, Mary Ann Lukas, David M Tenero, et al.
Journal of the American College of Cardiology|October 19, 2006
Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomesThomas Rutledge, Veronica A Reis, Sarah E Linke, et al.
The American Journal of Cardiology|October 7, 2006
COMPARE: comparison of the effects of carvedilol CR and carvedilol IR on left ventricular ejection fraction in patients with heart failureBarry H Greenberg, Mandeep Mehra, John R Teerlink, et al.
Journal of Molecular and Cellular Cardiology|March 1, 2005
IL-1beta and TNF-alpha upregulate angiotensin II type 1 (AT1) receptors on cardiac fibroblasts and are associated with increased AT1 density in the post-MI heartDevorah Gurantz, Randy T Cowling, Nissi Varki, et al.
Congestive Heart Failure (Greenwich, Conn.)|September 16, 2009
Sleep and health-related quality of life in heart failurePaul J Mills, Joel E Dimsdale, Loki Natarajan, et al.
JACC. Heart Failure|March 14, 2021
Thromboembolism in Heart Failure Patients in Sinus Rhythm: Epidemiology, Pathophysiology, Clinical Trials, and Future DirectionAndrew Y Lin, Elisabetta Dinatolo, Marco Metra, et al.
Journal of Cardiac Failure|April 3, 2012
Design and performance of a multisensor heart failure monitoring algorithm: results from the multisensor monitoring in congestive heart failure (MUSIC) studyInder S Anand, W H Wilson Tang, Barry H Greenberg, et al.
Brain, Behavior, and Immunity|February 17, 2009
Circulating levels of soluble intercellular adhesion molecule-1 (sICAM-1) independently predict depressive symptom severity after 12 months in heart failure patientsPetra H Wirtz, Laura S Redwine, Sarah Linke, et al.
American Journal of Physiology. Heart and Circulatory Physiology|May 10, 2005
Effects of cytokine treatment on angiotensin II type 1A receptor transcription and splicing in rat cardiac fibroblastsRandy T Cowling, Xiaowei Zhang, Vanessa C Reese, et al.
American Journal of Physiology. Heart and Circulatory Physiology|July 19, 2005
Angiotensin-(1-7) binds to specific receptors on cardiac fibroblasts to initiate antifibrotic and antitrophic effectsMichikado Iwata, Randy T Cowling, Devorah Gurantz, et al.
Pageof 15